Codexis (CDXS) Peer Comparison

$1.59

$-0.07 (-4.22%)

As on 28-Aug-2026 16:00EDT

Market cap

$174 Mln

Revenue (TTM)

$78 Mln

P/E Ratio

--

P/B Ratio

5.5

Div. Yield

0 %

Edit

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	174	16,765	16,261	13,492	11,994
Revenue ($ Mln)	78	2,782	1,054	2,436	670
Net Profit ($ Mln)	-30.72	491.50	755.85	860.62	-319.95
Net Margin (%)	-39.55	17.67	71.69	35.33	-47.79
RoE (%)	-73.60	110.09	--	42.98	-71.14
Price to Earnings	--	35.25	19.00	17.40	--
Price-To-Book	5.52	39.29	9.76	7.42	26.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	77.68	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	12.65	1,982.07	103.47	85.67	19.14
Gross Profit	61.05	760.62	588.53	2,236.43	829.45
Operating Expenses	89.28	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-24.26	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-30.65	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.07	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-30.72	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	32.96	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	63.59	187.89	384.48	288.55	1,362.63
Current Liabilities	23.51	1,435.43	464.70	361.93	283.35
Total Liabilities	147.80	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	48.14	1,006.90	895.24	1,243.41	440.60
Current Assets	71.92	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	147.80	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	72.59	120.10	449.89	165.93	864.07
Net Current Assets	0.00	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-19.38	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	23.50	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	27.93	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-35.10	53.56	-30.01	32.82	-0.17
ROE (%)	-73.60	110.09	163.18	42.98	-71.14
ROA (%)	-17.79	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-37.80	21.13	5.73	31.04	-0.77
Net Margin (%)	-39.55	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	35.89	24.67	114.85	9.23	12.22
EBIT Growth (%)	50.30	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	52.72	17.50	378.76	42.89	-115.58
EPS Growth (%)	58.63	26.84	353.27	50.42	-73.87
Book Value Growth (%)	-44.44	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-3.37	36.06	-59.76	15.79	-2,869.63
Price / Book Value	5.52	39.29	9.76	7.42	26.87
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.00
EV/EBITDA	-7.83	27.43	211.41	12.12	-81.53
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.31	0.00	0.05	0.00	0.09
Current Ratio	3.06	0.73	2.99	3.46	5.90
Quick Ratio	2.99	0.73	2.32	3.38	5.90
Interest Coverage	-6.34	--	1.62	--	-1.72

Operating Efficiency Ratios

	Codexis (CDXS)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	9.46	15.88	21.25	13.74	1.28
Asset Turnover	0.45	0.89	0.37	0.83	0.34
Receivable days	76.83	50.42	85.52	43.48	1.50
Inventory Days	70.72	--	1,056.70	96.17	--
Payable days	85.90	6.26	331.01	147.97	221.81
Cash Conversion Cycle	61.66	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly